Skip to main content
EJNMMI Radiopharmacy and Chemistry
Fig. 4 | EJNMMI Radiopharmacy and Chemistry

Fig. 4

From: In vitro characterisation of [177Lu]Lu-DOTA-C595 as a novel radioimmunotherapy for MUC1-CE positive pancreatic cancer

Fig. 4

Clonogenic survival of A PANC-1 and AsPC-1 at varying concentrations of [177Lu]Lu-DOTA-C595, B PANC-1 and C AsPC-1 cell survival following exposure to equivalent concentrations of [177Lu]Lu-DOTA-C595, Lu-177, DOTA-C595 and C595 and D intra-observer reliability of manual counting determined using the intra-class correlation coefficient (ICC). Data are presented as mean ± standard deviation. *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page